Obio Technology (Shanghai) Corp., Ltd. (SHA:688238)

China flag China · Delayed Price · Currency is CNY
7.74
+0.17 (2.25%)
At close: Jan 23, 2026
69.00%
Market Cap4.77B
Revenue (ttm)244.64M
Net Income (ttm)-294.16M
Shares Out630.31M
EPS (ttm)-0.46
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume11,512,816
Average Volume12,613,623
Open7.57
Previous Close7.57
Day's Range7.55 - 7.76
52-Week Range4.49 - 9.20
Beta0.57
RSI64.19
Earnings DateApr 21, 2026

About SHA:688238

Obio Technology (Shanghai) Corp., Ltd., a biotechnology company, engages in the provision of technical services for the field of regenerative medicine and anti-aging in China. The company offers customized plasmid design and viral vector packaging services; AAV serotypes and tissue-specific promoters to support scientific research; and research grade, NHP Grade, cGMP grade vector manufacturing process, for basic research, translational research and clinical trials. It also provides CDMO services encompassing process development, analytical meth... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2013
Employees 692
Stock Exchange Shanghai Stock Exchange
Ticker Symbol 688238
Full Company Profile

Financial Performance

In 2024, SHA:688238's revenue was 248.15 million, an increase of 21.16% compared to the previous year's 204.81 million. Losses were -321.81 million, 151.5% more than in 2023.

Financial Statements